🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research is to compare how safely and how well this med...
Status
Completed
Location
Children's Hospital of Wisconsin
Start Date
2003-12
Trial ID
NCT00199966
Treatments Being Tested
Bioavailability is the extent and rate to which the active drug ingredient ...
Status
Unknown
Location
Department of Pharmacy, Kathmandu University
Start Date
2023-08-06
Trial ID
NCT05641649
Treatments Being Tested
The goals of this study are: A. To determine whether olanzapine can help p...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test
Start Date
2004-10
Trial ID
NCT00094549
Treatments Being Tested
This is a single center, open-label, fixed sequence, drug-drug interaction ...
Status
Completed
Location
Syneos Health Clinical Research Services, LLC.
Start Date
2021-05-13
Trial ID
NCT04902105
Treatments Being Tested
This study compared the efficacy of lithium, divalproex, and placebo in tre...
Status
Completed
Location
University of Cincinnati Medical Center/Medical Sciences Building
Start Date
2001-03
Trial ID
NCT00221429
Treatments Being Tested
This is a 12-week study that will test the safety and efficacy of asenapine...
Status
Completed
Location
Multiple Locations
Start Date
2005-06-02
Trial ID
NCT00145470
This Phase 2 study (EPIMODE) will evaluate the efficacy and safety of CS1 c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-15
Trial ID
NCT07761572
The purpose of the study is to assess the safety profile of the investigati...
Status
Completed
Location
Neurology Clinic, P.C.
Start Date
2005-02
Trial ID
NCT00102713
Treatments Being Tested
The Optimal Treatment for Treatment-resistant Schizophrenia...
Status
Unknown
Location
DTliu
Start Date
2016-11
Trial ID
NCT02926976
The proposed study is a non-randomized, open label trial that will examine ...
Status
Terminated
Location
University of Pittsburgh Medical Center
Start Date
2008-04
Trial ID
NCT00665444
Treatments Being Tested